Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study

Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study

Background/purpose: This retrospective study evaluated the efficacy and adverse effects of oxaliplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) with secondary cytoreductive surgery (CRS) in patients with recurrent ovarian cancer. Methods: Patients diagnosed with recurrent epithelial o...

Full description

Saved in:
Bibliographic Details
Main Authors: Hua-Hsi Wu, Peng-Hui Wang, Yi-Jen Chen, Wei-Ting Chao
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Journal of the Formosan Medical Association
Subjects:
Acute kidney injury
HIPEC
Oxaliplatin
Recurrent ovarian cancer
Secondary cytoreduction
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664624003826
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items